Evolution Research Group | Endeavor Clinical Trials
Status and phase
Conditions
Treatments
About
This Phase 1b study of DISC-0974 will assess the safety, tolerability, pharmacokinetics (PK) and Pharmacodynamics (PD) of DISC-0974 in adult participants with Non-Dialysis Dependent Chronic Kidney Disease and Anemia.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
32 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Disc Medicine Clinical Trials
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal